(3) False-negative analysis was conducted by artificially augmenting the reported incidence of GLP-1RA-associated SSIBs by 100%, aiming to ascertain whether the absence of positive findings could be attributed to our exclusion of some cases involving the concurrent use of multiple GLP-1RAs
Halawi H, Khemani D, Eckert D, et al
The price of GLP-1 medications is high because pharmaceutical companies have spent billions of dollars on research and development (R&D), clinical trials, regulatory approvals, and marketing
Founded in early 2023, it's a relatively new entrant building its identity through manufacturing and distribution across India and potentially abroad
Oxidant chemotherapy: in vivo, L-carnitine did not interfere with doxorubicin cytotoxic effects (Sayed-Ahmed 1999)